Last update 22 Feb 2024
GSK Plc

GSK Plc

Public Company|
1929|
United Kingdom
|
10,000-50,000
| LON: GSK|

Overview

Tags

Infectious Diseases
Respiratory Diseases
Immune System Diseases
Small molecule drug
Prophylactic vaccine
Monoclonal antibody

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Top 5 Drug TypeCount
Small molecule drug238
Prophylactic vaccine73
Monoclonal antibody32
Vaccine30
Unknown17

Pipeline

Pipeline Snapshot as of 25 Feb 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
20
83
Preclinical
IND Approval
1
71
Phase 1 Clinical
Phase 2 Clinical
84
27
Phase 3 Clinical
NDA/BLA
2
157
Approved
Other
1428
Login to view more data

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
Unearth financing trends to validate and advance investment opportunities.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free